VAERS reports by lot

Merck HPV lot L004014: VAERS reports

35 VAERS reports list lot L004014 as a Merck HPV vaccine, received between 2015-08-14 and 2017-07-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
3%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological922%
General / Systemic (non-local)820%
Injection-site / Local reaction717%
Musculoskeletal615%
Cardiac / Cardiovascular37%
Allergic / Anaphylactic25%
Respiratory25%
Psychiatric / Neuropsychiatric25%
Gastrointestinal12%
Dermatological (non-injection-site)12%

Where reports came from

U.S. state of the reporter, where given (top 12).

West Virginia8
Illinois3
Ohio2
Rhode Island2
New Jersey2
Georgia1
Louisiana1
Tennessee1
South Carolina1
Texas1
Kentucky1
Maryland1

Reports by month received

2015-083
2015-095
2015-101
2015-111
2015-122
2016-012
2016-022
2016-047
2016-055
2016-111
2017-031
2017-043
2017-072

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.